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Background: The European Community recommends the implementation of population-based screening
programmes for cervical, breast, and colorectal cancers. This recommendation is supported by many observational
studies showing that organised programmes effectively reduce mortality and control the inappropriate use of
screening tests. We conducted a systematic review of studies assessing the efficacy of interventions to increase
participation in organised population-based screening programs.
Methods: We included all studies on interventions aimed at increasing screening participation published between
1/1999 and 7/2012. For those published before 1999, we considered the Jepson et al. (2000) review (Health Technol
Assess 4:1-133, 2000).
Results: Including studies from the Jepson review, we found 69 with quantitative information on interventions in
organised screening: 19 for cervical, 26 for breast, 20 colorectal cancers, and 4 for cervical and breast cancer
together.
Effective interventions were: postal (breast RR = 1,37 95% Confidence Interval (95% CI): 1.25-1.51; cervical RR = 1.71
95% CI: 1.60-1.83; colorectal RR = 1.33 95% CI: 1.17-1.51) and telephone reminders (with heterogeneous methods for
implementation); GP’s signature on invitation letter (breast RR = 1.13 95% CI: 1.11-1.16; cervical RR = 1.20 95%
CI: 1.10-1.30; colorectal RR = 1.15 95% CI: 1.07-1.24); scheduled appointment instead of open appointment (breast
RR = 1.26 95% CI: 1.02-1.55; cervical RR = 1.49 95% CI: 1.27-1.75; colorectal RR = 1.79 95% CI: 1.65-1.93). Mailing a kit
for self-sampling cervical specimens increased participation in non-responders (RR = 2.37 95% CI: 1.44-3.90).
Conclusion: Although some interventions did prove to be effective, some specific variables may influence their
effectiveness in and applicability to organised population-based screening programs.
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Most government agencies and scientific societies [1,2] rec-
ommend cervical, breast, and colorectal screening because
of the burden of these cancers, the availability of screening
tests, and the proven efficacy of screening in reducing mor-
tality (as well as incidence, for cervical and colorectal can-
cers) [3-5]. Indeed, many observational studies have shown
that organised programmes effectively reduce mortality
and control the inappropriate use of screening tests [6-9].* Correspondence: paolo.giorgirossi@ausl.re.it
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reproduction in any medium, provided the orThe European Community thus recommends imple-
menting organised screening programmes that actively in-
vite the target population [1], primarily by means of a
letter mailed at regular, pre-determined intervals to target
individuals, and many Member States have done so [10].
Public screening programmes must achieve high com-
pliance to be effective and efficient, yet participation is
low in many countries despite standard invitations and
recall systems. In some cases, low participation results
in low Pap-test coverage, with a relevant impact on cer-
vical cancer incidence [11]. In other cases, low participa-
tion is due to the greater use of private opportunistic
screening [12,13], which does not of course necessarilyal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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public screening programmes produces negative effects,
mostly in terms of the reduced efficiency and quality of
the health system.
As high participation in screening is the primary goal
of all organised programmes, more and more attention
has been paid recently to how to engage citizens in pub-
lic health programmes. The concept of informed con-
scious participation is now considered the standard for
each intervention aimed at influencing citizens’ behav-
iours [14], particularly when participation in secondary
prevention is not completely free of any risk of unneces-
sary assessments, overdiagnosis, or even possible over-
treatment [15].
Several interventions have been proposed to increase
participation and many quantitative experimental studies
have been conducted to evaluate their effectiveness. In
2000, Jepson R et al. [16] conducted a monumental sys-
tematic review and HTA report.
Some systematic reviews since then have focused on a
specific type of screening, such as Cochrane reviews on in-
terventions for increasing the uptake of breast or cervical
screening [17-19], while others have concentrated on spe-
cific types of interventions, for example the Cochrane re-
views concerning “personalized risk communication” [20]
or “patient decision aids” [21]. Others still have examined
specific populations [22], and finally, some have investi-
gated outcomes related to participation, like the impact of
female screening on future behaviours and health beliefs
of women [23], or the impact of interventions to improve
attendance to female cancer screening among lower socio-
economic groups [24].
As none of these reviews focused on organised screening
programmes, the comparators differ: what is considered an
intervention in one study may be the control in another.
We conducted a comprehensive systematic review of
interventions to increase participation in organised
cervical, breast, and colorectal screening programmes,
using the standard invitation letter as comparator for
all the proposed interventions. The aim of this paper is
to present the results of that systematic review.
Methods
Identification of studies: inclusion and exclusion criteria
The target population of cancer screening in Italy is
women from 50 to 69 years for breast cancer screening,
women between 25 and 64 years for cervical cancer
screening, and men and women between 50 and 70 years
for colorectal cancer screening. We thus excluded all stud-
ies whose target populations were outside recommended
target age.
We included all studies on interventions, strategies, or
programmes aimed at increasing participation in the
three cancer screenings mentioned above.Studies comparing interventions versus usual care (in-
cluding no intervention) and comparisons between differ-
ent interventions were included in the overall review [25].
A comparison between opportunistic screening methods
(including no intervention) versus organized screening,
and opportunistic screening methods versus no interven-
tion were reported in another article [26]. That paper
compared different interventions to increase the participa-
tion in an organized screening setting only. We, instead,
also included studies conducted in the spontaneous
screening setting but only when one group received an in-
vitation letter, with or without a reminder. The compara-
tor was thus always the postal invitation letter.
The efficacy of the interventions was evaluated in
terms of the increased participation in the first level test
of the program.
Randomized controlled trials, experimental studies,
and before and after studies were included for quantita-
tive analysis. Studies were included if published between
1999 and 07/2012. No language restriction was used. A
search of grey literature, including international guide-
lines, laws, and national and European documents, was
then carried out. Studies found were then classified
based on the screening context (organised or spontan-
eous) and on country of origin.
Exclusion criteria for the entire review were: different
target population or strongly pre-selected population;
attitudes or perceived outcomes; no control; serious
methodological flaws impeding a comparison between
intervention and control.
In this paper we present the results of studies on inter-
ventions aimed at increasing participation that can be
implemented as part of organised screening programmes,
compared to the standard invitation letter. Consequently,
criteria for exclusion from the analyses reported in this
paper also include interventions that could not be imple-
mented in organised screening programmes and there not
being at least one arm with invitation letter (alone or with
a recall). We also do not present results related to inter-
ventions comparing different types of test for colorectal
cancer screening [27].
Search strategy and data extraction
The following electronic databases were searched:
PubMed, EMBASE, Cochrane, PsycINFO, LILACS, HTA
and CRD databases. The Italian grey literature was re-
trieved through a search of regional websites, the Italian
Ministry of Health website, and the National Centre for
Screening Monitoring (ONS) website. For the European
grey literature we searched the sites of all the Ministries
of Health (MoH) of member states, the European Com-
munity, and the International Agency for Research on
Cancer (IARC) websites. Other articles were found by
crosschecking the bibliographic citations of selected
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of European and of Italian Ministry of Health projects.
Search terms used in PubMed are reported in Additional
file 1; for the other sources the same keywords with appro-
priate syntax changes were used. The literature search was
based on the strategy used by Jepson et al. [16] in their sys-
tematic review. All possible language variations for funda-
mental terms (participation and types of cancer screening)
were used. The strategy was validated by checking whether
it was able to identify all the cervical, breast, and colorectal
cancer screening related papers included in the Jepson
et al. [16] review on interventions. Some adjustments to in-
crease the sensitivity were also applied to create the final
strategy search described in the Additional file.
Titles were first perused by a researcher to eliminate
articles not relevant to our research. A second assess-
ment was made on the relevance of information found
in the abstracts, with potentially relevant papers selected
for the quantitative assessment of effectiveness. Full
texts of these articles were then retrieved. Excluded
studies were still considered potentially relevant for a
qualitative assessment of the interventions.
Data extraction from quantitative studies was per-
formed by one researcher. Information extracted in-
cluded author, year, title, place of study, type of study,
sample number, population included, setting, type of
screening, intervention and control, main outcome re-
sults as reported by the authors, authors’ conclusions,
and comments. A second researcher extracted all the
numeric data relevant for the quantitative analysis and
the estimated variance and then evaluated their accuracy
in the assessment of uncertainty. Extracted data are
reported in the Additional file 2.Quality assessment of the studies
The quality of the included studies was evaluated by a
researcher using specific instruments. For trials assess-
ment, the CONSORT list [28] was used. The related
CASP [29] criteria and the Cochrane Collaboration tool
for risk of bias identification were then applied to
synthesize the CONSORT checklist results in a qualita-
tive analysis. Observational or almost-experimental stud-
ies, for which the CONSORT list is not appropriate,
were assessed with the STROBE checklist [30] for cohort
studies or cross-sectional studies. The CASP criteria
were then used to judge the quality.
Reasons for exclusion were reviewed by other two re-
searchers independently. In case of disagreement on ex-
clusion, the checklist process was repeated. If, again, no
agreement was reached, the final decision regarding the
exclusion of a study was taken by the principal investiga-
tor (PGR). The results are reported in the Additional file
3 and Additional file 4.Classification of intervention
Interventions to increase participation in screening
programmes were classified into:
 Interventions aimed at the target population:
◦ Individuals: invitation (letters or telephone calls)
and reminders to non-responders.
◦ Population: educational information, delivery of
publicity through different types of media.
 Interventions to simplify screening tests: offering
test at routine consultations or sending it by mail,
improving screening test options, and/or offering
new test or procedures.
 Interventions related to human resources
management: training on screening programmes
 Interventions related to health services
management: removing administrative, economic,
geographic, and/or time-related barriers.
Data syntheses
For each comparison a synthesis of the intervention’s ef-
fect with respective 95% confidence intervals and a test
of heterogeneity were calculated.
Fixed effects model was fitted if the heterogeneity was
not significant, while the random effect model was used
in the presence of significant (p < 0.05) heterogeneity.
The data were analyzed using Review Manager 5 (the
Cochrane Collaboration).
Analyses were carried out by type of screening (breast,
cervical, or colorectal cancer screening).
Results
The selection process of relevant studies is described
elsewhere [26]. Briefly, titles of 10,740 potentially rele-
vant citations were identified and screened; of these,
1,051 abstracts were selected. Of these, 860 studies were
deemed not useful for a quantitative analysis, while 191
were selected for a full-text revision. Ninety-two quanti-
tative studies fulfilled inclusion criteria; the rest irrele-
vant quantitative studies were excluded. Another 74
studies from the Jepson review were added (Figure 1).
In brief, the main reasons for exclusion were related to:
studies with patient ages different from European recom-
mendations on screening target population; strongly se-
lected population through a questionnaire or a request for
the service; specific target population as well as foreign
community or high-risk subjects; outcomes other than test
execution, such as liking, tendency, or intention. Methodo-
logical quality flaws, which made minor contributions to
exclusion, were: absence of a comparator, no clear out-
come, or inconsistency between randomization and results.
Of the 166 papers included in our systematic review,
our final analysis included 69 studies related to interven-
tions to increase participation in organised screening
Potentially relevant 
citations (titles) identified 
and screened (n=10,740)
Potentially relevant 
abstracts identified and 
screened (n=1,051)
Retrieve full text for critical 
appraisal (n=191)
QT Studies fulfilled 
inclusion criteria (n=92)
Excluded irrelevant citations  
(n=9,689)
Excluded abstracts without 
quantitative information 
(n=860)
Excluded from the review






review (n=74) Studies fulfilled inclusion 
criteria (n=166)
Studies included in the 
Review (n=69)
Not included in the present paper:
opportunistic screening and 
comparison between tests 
combinations for CRC (n=97)
Figure 1 Flowchart of included and excluded studies.
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no intervention or opportunistic strategies or compared
different kinds of test for colorectal cancer screening.
Quality assessment and risk of bias
The CONSORT list was used to assess the trials and the
STROBE checklist for cohort studies or cross-sectional
studies was used to evaluate observational or almost-
experimental studies. For studies extracted from the
Jepson review, the quality assessments performed by the
authors were held to be valid.
Although the literature was quite recent, a description
of randomization methods was missing in several studies.Study and country
Cervical
Eaker 2004  Sweden
Morrell 2005  Australia
Total (95% CI)
Total events
Heterogeneity: Chi² = 37.31, df = 1 (P < 0.00001); I² = 97%
Test for overall effect: Z = 16.18 (P < 0.00001)
Breast
King 1994  USA
Page 2006  Australia
Taplin 1994  USA
Total (95% CI)
Total events
Heterogeneity: Chi² = 2.47, df = 2 (P = 0.29); I² = 19%
Test for overall effect: Z = 6.81 (P < 0.00001)
Colorectal






































Figure 2 Effect on screening program participation of mail recall in aFunding was often not clearly described, and almost no
study utilized masking techniques or blinding of assessors.
The follow up completeness was complete and unbiased
in most cases by definition, i.e. lost to follow up coin-
cided with failure (see Additional file 1, Additional file
2, Additional file 3 and Additional file 4).
Of the six studies that adopted a cluster randomization,
5 did not account for it in the analysis. Study power and
the lost to follow up were checklist items that were poorly
reported.
Interventions to increase participation in organized
screening programs
Interventions conducted in an opportunistic setting were
included when there were at least two experimental
arms: one mailed an invitation letter and the other
consisted of mailing the letter plus additional interven-
tion. In this review we only considered the comparison
between letter (considered our standard of care) and let-
ter + other intervention.
Interventions are reported by target: individual, po-
pulation, health workers, tests, and health service
management.
Interventions to individual
Postal reminders (Figure 2)
Six studies compared mailing a letter with mailing a
letter plus a postal reminder [31-36]. Three of these,









Risk Ratio Risk Ratio
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Favours letter Favours letter+recall
ddition to invitation letter vs invitation letter alone.
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the intervention.
Two large pragmatic studies reported an increase in
participation for cervical screening; [31,32] one included
only non-responders in the study population, increasing
the RR’s magnitude [31]. The other study [36] showed a
significant absolute increase in compliance for colorectal
cancer screening.
Telephone recall (Figure 3)
Several studies compared postal invitations with postal
invitations plus telephone reminder. These studies com-
pared various combinations of interventions: letter + letter
(L + L) vs letter + telephone recall (L + T); only letter (L)
vs letter + telephone recall (L + T); letter + letter (L + L) vs
letter + letter + telephone recall (L + L + T).
For mammogram screening, data from eleven studies
were available. Five of them [37-41] compared L vs L +
T, and two of them compared L + L vs L + T [42,43],
while another three studies made both comparisons withStudy and country
Cervical
Eaker 2004  Sweden [31] 
Heranney 2011  France [47] 
Oscarsson 2007  Sweden [46] 
Vogt 2003  USA [43] 
Breast
Bodiya 1999  USA [37] 
Davis 1997  USA [44] 
Hegenscheid 2011  Germany [38] 
King 1994  USA [33] 
Mayer 1994  USA [39] 
Page 2006  Australia [35] 
Püschel 2010  Chile [40] 
Richardson 1994  N.Zealand [42] 
Rimer 2002  USA [41] 
Vogt 2003  USA [43] 
Colorectal
Myers 1991  USA [49] 
Myers 1994  USA [50] 
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Valanis 2002  USA [48] 
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L+T vs L+L
Valanis 2002  USA [48] 129 4225L+T vs L+L

















Page 2006  Australia [35] 61 785 67L+T vs L+L
Davis 1997  USA [44] 37 131 12L+T vs L+L
Figure 3 Effect on screening program participation of phone call rem
mail recall.factorial designs [33,35,44]. The 11th study found, by
Gierisch et al. [45], tested different types of telephone
counselling. None of these studies had a large sample
size and/or a pragmatic design. Results were statistically
heterogeneous. The three studies with the L + L vs L +
T comparison showed strongly contrasting data: no ef-
fect for Richardson et al. [42] and strong positive effect
for King et al. [33] and Vogt et al. [43]. The same thing
occurred for studies comparing L vs L + T: one study
found no effect, [39] while three others reported a sig-
nificant effect [37,40,41]. Also Page et al. [35] reported
an advantage for telephone call reminders in the com-
parison L vs L + T, but that advantage disappeared in
the comparison L + L vs. L + T. The advantage was not
present in the comparison L + L vs L + L + T [38]. On
the contrary, Davis et al. [44] found an advantage for
telephone call reminders in both comparisons. Gierisch
et al. [45] (not reported in Figure 3) found a reduction
in the number of days of non-adherence, from 222 in
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127 1.71 [1.11, 2.62]
127 1.79 [1.12, 2.74]
785 0.91 [0.65, 1.27]
131 3.08 [1.68, 5.64]
inder in addition to invitation letter vs invitation letter and
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http://www.biomedcentral.com/1471-2458/13/464types of telephone counselling, one focusing on barriers
only and the other on barriers and positive effects of
screening (p 0.004 and 0.0008, respectively).
For cervical screening, five studies were included: two
compared L vs L + T [31,46] and three compared L + L vs
L + T [43,47,48]. All found an advantage for telephone call
reminders, although there was heterogeneity, with the
largest study [47] showing a modest, non significant effect.
For colorectal screening, three studies were found. In
1991, Myers et al. [49] compared L vs L + T, and in
1994, L + L vs L + L + T [50]. A significant increase wasStudy or Subgroup
Cervical
Segnan 1998  Italy
Stein 2005  UK
Breast
Mayer 1994  USA
Meldrum 1994  UK
Segnan 1998  Italy
Simon 2001 USA
Colorectal
Cole 2007  Australia
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Ahmed 2010 USA 213 786 126 785
a. Face to face interventions vs letter
b. Different types of letter. See text for a descri
Figure 4 Effect on screening program participation of face-to-face intfound in both cases. Thompson et al. [51] found a slight
non-significant advantage to the addition of telephone
calls to two types of interventions (letter and GP contact).
Finally, one study [48] compared a personalized letter
followed by a telephone call vs. a simple letter for Pap
test and mammography and found an advantage of the
intervention over the simple letter.
Face-to-face intervention (Figure 4a)
We found seven studies that evaluated the effect of a
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the intervention to a control arm (invitation letter plus a
reminder letter).
For mammogram screening, data from six studies
[52-57] were included, although only one had large sam-
ple size and a pragmatic approach [52]. Three found a
significant increase [54-56], while two found no effect
[53,57]. The sixth study, with a stepwise design [52],
found a two-fold increase in participation compared to
the letter (RR 2.35 95% CI 1.69-3.15).
For colorectal screening, only one study was found
[58], which reported a statistically significant increase in
compliance (RR 1.29 95% CI 1.14–1.45).
No study with this type of intervention was found for
cervical screening.
The specific nature of each intervention did not make
it possible to identify any elements in common, with the
exception of the fact that they all required many re-
sources and that, because of small sample size or be-
cause of a selection of the population through a stepwise
design [52], they were tested on few persons.
Different types of letters compared each other (Figure 4b)
Data from eight papers, reporting ten studies, are in-
cluded: three for breast, three for colorectal, one for cer-
vical cancer, and one for breast and cervical screening.
Regarding mammogram screening, the addition of a
gift to the standard invitation letter showed no efficacy
in the Mayer et al. study [39] (RR 0.89 95% CI 0.60-
1.33). Likewise, no difference was found between a letter
for physician referral and a letter for direct access [59]
(RR 0.89 95% CI 0.69-1.16). Other studies with larger
sample sizes evaluating the use of tailored letters [60] or
personal letter with extended text [61] had no significant
impact on compliance.
Concerning colorectal cancer screening, two studies
[62,63] evaluated the impact of advance notification vs
the standard invitation. The studies obtained similar re-
sults and the pooled effect was a 14% increase in screen-
ing compliance (RR 1.14 95% CI 1.08-1.19, data not
shown in figure). Another study, conducted in Italy [64],
compared the use of an invitation letter signed by differ-
ent healthcare-related professionals: a GP, a well-known
scientist, or the study coordinator. No difference in com-
pliance was found.
Data from one small English study [65] and an Italian
study [61] with a larger sample are reported for cervical
cancer screening. The first study compared a letter from
a public health doctor (local authority) vs a letter from a
celebrity: a large but not significant effect was found (RR
2.60, 95% CI 0.94-7.20). The second study compared a
personal letter with extended text vs a personal letter:
no effect was found on overall participation, but the ex-
tended text did increase the difference in response ratebetween women with low educational level and high
educational level, in favour of the latter.
GP’s signature on the invitation letter (Figure 5)
Six papers on mammogram screening, [34,42,52,55,66,67]
one on cervical [68], three on colorectal [64,69,70], and one
on cervical and mammogram [61] screening evaluated the
positive effect of the GP’s (often electronic) signature
(Figure 5) on the invitation letter, compared to a standard
letter generally signed by a local health service provider.
Only two papers presented three large pragmatic stud-
ies (mammogram screening) [61,66]: the paper by Giorgi
(2000) tested a letter co-signed by GP and programme
coordinator in one screening programme, while in other
two studies the GP signed only the reminders. The other
four studies [34,42,55,67], with smaller samples, tested
invitation letters signed by the GP. Pooled estimate
was a modest advantage in favour of the GP-signed let-
ter: +13% (95% CI 11–16). Heterogeneity was low and
only one study [34] found a slightly negative, non-
significant result. A study with a stepwise design found
an increase in participation in low-income women
when adding a letter signed by the GP to that signed by
the health provider (RR 1.8 95%CI 1.2-2.69; not in-
cluded in figure) [52].
Both cervical screening studies leaned towards an ad-
vantage of the GP letter, although they were heteroge-
neous: RR 1.17 (95% CI 1.07-1.27) for Segnan et al. [61]
and RR 1.84 (95% CI 1.21-2.81) for Bowman et al. [68].
For colorectal screening the pooled effect was RR 1.15
(95% CI 1.07-1.24) without heterogeneity.Additional informational material (Figure 6a)
Ten studies evaluated the effect of including pam-
phlets, leaflets, and booklets with the invitation letter
[31,44,49,56,62,70-74]. Although fundamental points in
these materials were rather homogeneous, interventions
were not entirely comparable.
For breast cancer screening, two small sized studies
were found [44,56]; neither reported a significant effect,
and the results were conflicting.
For cervical cancer, two studies were included [31,72] al-
though only one provided us with information thanks to
the power of the study. However, no effect was found [31].
Finally, six studies were found for colorectal cancer, all
with sufficient power [49,62,70,71,73,74], with results
generally highlighting no impact. Only two studies
showed modest positive significant results [70,71], while
another study provided significant opposite results [74].
Educational individual intervention (Figure 6b)
Three studies were found [75-77] - one for each type of
screening – that evaluated the effect of education/health
Study and country
Cervical
Bowman 1995  Australia
Segnan 1998  Italy
Total (95% CI)
Total events
Heterogeneity: Chi² = 4.32, df = 1 (P = 0.04); I² = 77%
Test for overall effect: Z = 4.19 (P < 0.0001)
Breast
Giorgi 2000  Italy all target pop.
Giorgi 2000  Italy non-responders
O' Connor 1998  UK
Richardson 1994  New Zealand
Segnan 1998  Italy
Segura 2001  Spain
Taplin 1994  USA
Total (95% CI)
Total events
Heterogeneity: Chi² = 9.87, df = 6 (P = 0.13); I² = 39%
Test for overall effect: Z = 11.71 (P < 0.00001)
Colorectal
Cole 2002  Australia
Hewitson 2011  UK
Senore 1996  Italy
Total (95% CI)
Total events
Heterogeneity: Chi² = 1.61, df = 2 (P = 0.45); I² = 0%
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M-H, Fixed, 95% CI
0.1 0.2 0.5 1 2 5 10
letter letter from GP
Figure 5 Effect on screening program participation of GP signature on invitation letter vs standard invitation letter.
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http://www.biomedcentral.com/1471-2458/13/464promotion interventions; all showed significant positive
effects ranging from 20% to 30%.
Interventions on the population
In this section interventions that targeted communities
or entire populations, in addition to the systematic invi-
tation of the target population by letter, were evaluated.Mass media campaigns
Only one study [78] evaluated the effect of mass educa-
tional campaigns in addition to invitations for Pap tests
in Australia. The study found a significant effect that in-
creased participation by 100% (RR = 2.00 95% CI 1.53-
2.61). A quasi-experimental study, it was not possible to
determine how many women among responders had
already been screened.
Community education interventions
Although many screening programmes create educational
campaigns and interventions aimed at communities,especially in the first years after activation, only three
studies evaluating the effectiveness of these interventions
were found: two from Australia [79,80] and one from the
USA [81].
Clover et al. [80] evaluated three different interventions
for mammography promotion in two sequential cluster
randomised trials: in the first, two towns were randomised
to media promotion (newspaper and radio advertisements)
and two to community participation (creation of a com-
mittee of community representatives). In the second, two
were randomised to community participation and two to
family practitioner involvement. In the first trial, commu-
nity participation intervention had a better effect than
media promotion intervention in both clusters (+29% and
+17%, p < 0.001 and p < 0.01). In the second trial, family
practitioner involvement intervention had a higher effect
compared with community participation intervention; that
effect was significant in one town (+17% p < 0.01), and
not significant in the other (+10% p = 0.1).
King et al. [81] compared three interventions: one was
education-based (with flier and a community education
Study and country
Cervical
Eaker 2004  Sweden
McAvoy 1991  UK
Breast
Davis 1997  USA
Seow 1998  Singapore
Colorectal
Cole 2007  Australia
Hart 1997  UK
Hewitson 2011  UK
Myers 1991  USA
Nichols 1986  UK
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Favours experimental Favours control
b. Educational intervention in addition to invitation letter vs. letter.
a. Printed information material in addition to invitation letter vs. letter.
Figure 6 Effect on screening program participation of printed information material (a) and of educational interventions (b).
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http://www.biomedcentral.com/1471-2458/13/464programme), one was based on removing barriers to mam-
mography access (with mammography appointments and
transportation), and the third was a combination of the first
two. Neither the educational intervention nor the combin-
ation had any effect, while a non-significant effect of +7%
(p = 0.08) was observed for barrier-removing intervention.
Finally, Brown et al. [79] compared an intervention
promoting cervical screening based on newspaper arti-
cles, leaflets, posters, and talks to women’s groups with
standard intervention, with six communities per arm be-
ing randomized. Although one community randomised
to the intervention arm did not participate in the study,
the authors noted a significant increase (p < 0.01) in the
number of women attending cervical cancer screening
even in the intention-to-treat analysis (+22%). There
were no corresponding increases in the comparison
region (−4%).For all studies, analyses did not adequately take into
account cluster randomization, so the variance could be
strongly underestimated and therefore the significance
overestimated.
Interventions to simplify the test
In this category we considered all studies evaluating the
effect on screening compliance of interventions aimed at
simplifying the testing or sampling procedures. Many
studies concentrated on the effect of mailing a device for
biologic sample self-collection directly to the home of
the target population. The only two tests currently avail-
able that allow self-sampling are the faecal occult blood
test (FOBT), for colorectal cancer, and the human Papil-
lomavirus (HPV) test, for cervical cancer.
Self-sampled cervical samples are only validated for
HPV testing, not for Pap test. Seven studies tested the
Camilloni et al. BMC Public Health 2013, 13:464 Page 10 of 16
http://www.biomedcentral.com/1471-2458/13/464effectiveness of this intervention on non-responders
[82-89], compared to a recall for Pap test at the clinic
(Figure 7a). All the studies observed positive effects al-
beit with different magnitudes. Only one pragmatic trial,
which was conducted in Mexico and which targeted the
whole population, not only non-responders, compared
the participation to HPV with self-sampling to invitation
to a clinic-based Pap test. A slightly lower compliance in
the self-sampling arm was observed, mostly due to those
women to whom the self-sampler was not mailed be-
cause they were not found at the address to which an
advance notice letter had been sent [90].
For colorectal cancer screening, six studies compared
mailing the FOBT sampling kit with an invitation to the
whole target population to pick up the kit at the clinic
[73,91-95] in order to determine whether the former
both increased compliance and reduced front office
workload (Figure 7b). Five of these studies, including
two large pragmatic trials [92,95], found a positive effect,
while the sixth [73], also a large pragmatic trial, found a
significant negative effect when compared to a scheduled
appointment with the GP but a positive effect when
compared to request to schedule an appointment.
Finally, only one study also tested a strategy of mailing
the kit to non-responders only and found a modest posi-
tive effect [93].Study and country
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One study [36] showed an effect of the reminder on
subjects who received the FOBT kit at home, with a
+33% increase in returned samples (p < 0.001).Intervention to health service management
Invitation appointments (Figure 8)
Five studies compared scheduled screening appointments
with open appointments: one for breast [96], one for colo-
rectal [73], two for cervical [97,98], and one for both breast
and cervical cancer screening [61]. Of these five studies,
two [61,73] were pragmatic trials with very high power.
All the studies found an advantage for scheduled ap-
pointments. For mammography, the pooled effect was RR
1.26% (95% CI 1.02-1.55), with significant heterogeneity
because of the high power of the studies. For cervical
screening, the pooled estimate was RR 1.49 (95% CI 1.27-
1.75), without substantial heterogeneity, while for colorec-
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Some studies evaluated organizational strategies to re-
duce logistic barriers related to the necessity of travelling
to undergo the tests.
One Italian study [99] evaluated the effect of using
GPs instead of a screening centre to hand out and return
the FOBT. The study showed a strong advantage of
using GPs (RR 3.1; 95% CI 2.9-3.4), but also underlined
the difficulties for GP involvement; in fact, only 25%
agreed to participate in the study.
A non-randomised Italian study [100] showed higher
participation when using pharmacies instead of a screen-
ing centre to hand out and return the FOBT.
Finally, another study [101] analyzed the use of mobile
mammography, finding a 20% increase in compliance (p <
0.01). However, this study presented several methodo-
logical limits about effect evaluation.
GP reminder in addition to the invitation letter
A systematic review of the studies evaluating GP involve-
ment through reminder systems for non-responders to the
invitation letter to the screening program, compared to
systematic mailings of an invitation letter, was carried out
as sub-project under the HTA program sponsored by the
Italian Ministry of Health [25,26].
Discussion
In our systematic review we tried to include all inter-
ventions aimed at increasing participation in oncologic
screening programmes, primarily following the frame-
work adopted by Jepson et al [16]. Since organisedpopulation-based screening is recommended by the
European Commission Guidelines and by Italian law, we
focused on the interventions that are applicable to
organised screening models and, from this point of view,
we defined “standard care” as the systematic invitation
of the whole target population.
Like the previous systematic review, we classified the in-
terventions according to their target: individuals, commu-
nities, health operators, or the health service organization.
In line with the conclusions of the previous systematic
reviews [16-19], letter or phone reminders can be con-
sidered evidence-based practices. We also confirmed the
evidence on effective interventions to reduce barriers,
particularly logistical, as well as the evidence on sched-
uled appointment compared to open appointments [16].
In our review recent papers confirmed that printed in-
formation material offers no advantage, reaching conclu-
sions that differ from those in Bonfill-Cosp’s review for
breast cancer screening. Recent papers also led us to
change the conclusion concerning the GP signature,
which was classified as scarce evidence in the previous
review [16], but which consistently proved effective in
our review, albeit with a modest effect. Our review con-
firms the scarcity of sound studies measuring the effect
of mass media campaigns and community-based inter-
ventions. Further, we found no new study evaluating
such interventions, meaning that there are still relevant
epistemological and methodological problems in produ-
cing evidence for complexes interventions, particularly
in prevention, but also that the interest in this field has
decreased over the last decade. Finally, we had the
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vice for HPV testing to increase cervical cancer screen-
ing participation; all the studies on this topic have been
published since 2010 and could therefore not be evalu-
ated in previous reviews and for which there was only a
non-systematic review [102].
It must be noted that we included for meta-analyses
only 40 out of 148 quantitative studies and reports. Few
were excluded because of poor methodology, while most
were excluded because their aim was to improve spon-
taneous screening and thus the results were not applic-
able to an organised screening model. In fact, most of
the studies we found in our search were conducted in
the USA, where spontaneous screening is the predomin-
ant model. As a consequence, these studies differ from
those conducted in Europe in that the American studies
are usually smaller, and framed within a spontaneous
screening model even when they test an organised
model. Consequently, they rarely take a pragmatic ap-
proach. Instead, most of the European studies are
framed within organised screening, which invites the tar-
get population by letter or through the GP. Conse-
quently, they usually have large sample sizes, use a
pragmatic approach, and test small variations in the
screening routine.
In the section on quality assessment and risk of bias,
we identified several problems concerning how the stud-
ies were reported. The randomisation and allocation
methods were poorly described; as the population exam-
ined in most of the studies was assigned to the interven-
tion or control before they received the service, the
researchers had no information regarding their pro-
pensity to respond, making any selection bias during
randomization and allocation impossible. Consequently,
most studies did not attempt any concealment of the al-
location. Also, funding and grants were not always speci-
fied; the vast majority of those that did not report this
information, however, were funded by public or non-
profit organizations, meaning that there may have been
a financial conflict of interest. Virtually none of the stud-
ies was conducted blind, given that the kind of interven-
tions used made blinding impossible for operators, and
given that the subjects were nearly always unaware of
their participation in a study. Formal blinding of assessor
was adopted in a few studies, but we must take into ac-
count that the outcome assessment in most studies was
conducted through automatic database check or by elec-
tronic record linkage, techniques which are quite im-
mune to ascertainment bias. Another poorly reported
checklist item was the loss to follow up. For most ex-
perimental and observational studies included in this
systematic review, loss to follow up by definition cannot
exist: the randomized, invited subject is a success if he/
she undergoes screening and a failure if he/she does not.So, while loss to follow up and failures are indistinguish-
able from each other, this does not invalidate the validity
of the comparison between the successes in the two
arms.
Of the 6 studies that adopted cluster randomization,
only one took this into account in the analysis. The
study’s power was one of the least-often provided check-
list items. It is very relevant for efficacy trials but not es-
sential for effectiveness trials, in which experimentation
and intervention implementation are very similar and
whose sample can coincide with the population.
Only a few studies requested patient consent for study
participation; most of these were excluded from the
quantitative analysis because the population evaluated
was pre-selected. We agree with most of the researchers
who did not request patient consent as the purpose was
not to study a new test but to study the organizational
modality used to offer it; the patient was in any case
utilizing a validated and evidence-based practice of
prevention.
Finally, most of the studies published after 2000 men-
tion the issue of informed participation, either in the
introduction or in the discussion. None of the included
studies, however, actually tried to measure the con-
sciousness of participants. There are intrinsic difficulties
in measuring informed consent in screening [103] and it
is possible that our including only quantitative studies
made finding the most appropriate literature on this
point difficult.
We used the CONSORT checklist and the Cochrane
risk of bias tool to guide our quality appraisal, although
these instruments were developed primarily for clinical
trials. Applying the criteria developed to evaluate pos-
sible biases in pharmacological trials to prevention trials
may lead to overestimating some risks and even to ig-
noring some others specific to those interventions that
are applicable to large, healthy populations.
The main limit of our analysis is that we included ran-
domized or experimental studies almost exclusively; there
is now a lot of observational data, however, some of it in
the grey literature, that may provide a great deal of infor-
mation on this topic. In fact, routine statistics of screening
program performance are available [104-106] and trend
data, as well as ecological analyses, may indicate which
strategies are more effective in improving participation.
The study comparing the Dutch cervical cancer screening
program use of family practice-based and the health ser-
vice clinic-based invitation system [107] is a good example
of the relevance of observational studies.Conclusions
Among the measures to increase participation in orga-
nized screening:
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http://www.biomedcentral.com/1471-2458/13/464 There is solid evidence of a modest positive effect of
postal reminders. There is also a positive effect of an
advance notification letter for colorectal cancer
screening. Telephone calls are generally more
effective, however, even though they have been
assessed for the most part in studies that have not
taken a pragmatic approach;
 Different styles of letter presentation may affect
participation. In particular, there is evidence that
long, detailed letters may increase inequalities in
participation, discouraging those with lower
educational level;
 There is solid evidence of a modest, positive effect
of the GP signing the invitation;
 Evaluations of public information campaigns have
had heterogeneous results;
 There is solid evidence of a positive effect of a
scheduled appointment compared to an open
appointment;
 Strategies to reduce logistical barriers, even with the
methodological limitations of the studies, seem to be
very effective;
 Mailing a self-sampling device to non-responders
significantly increases participation in cervical
cancer screening;
 Mailing the FOBT kit results in higher compliance
than does the invitation to pick up the kit at the
clinic; this could drastically reduce the workload for
screening services.
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